Larissa Dragonetti Bertin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Larissa Dragonetti Bertin has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Augusto Camillo
Laboratory for Studies of the Mucus Secretory System (LEAMS), Department of Physiotherapy, Faculty of Science and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-900, Brazil
5 shared publications - Camile Ludovico Zamboti
Departamento de Fisioterapia, Laboratório de Pesquisa em Fisioterapia Respiratória - LFIP - Universidade Estadual de Londrina, Londrina (PR) Brasil
4 shared publications - Fabio Pitta
Universidade Estadual de Londrina
4 shared publications - Gabriela Garcia Krinski
Departamento de Fisioterapia, Laboratório de Pesquisa em Fisioterapia Respiratória - LFIP - Universidade Estadual de Londrina, Londrina (PR) Brasil
4 shared publications - Emanuel Gois Junior
Departamento de Fisioterapia, Laboratório de Pesquisa em Fisioterapia Respiratória - LFIP - Universidade Estadual de Londrina, Londrina (PR) Brasil
2 shared publications - Heloise Angélico Pimpão
Departamento de Fisioterapia, Laboratório de Pesquisa em Fisioterapia Respiratória - LFIP - Universidade Estadual de Londrina, Londrina (PR) Brasil
2 shared publications
Latest Publications
- Open Access
- 4 February 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (1) , e20240248
Timed “up and go” to identify physically inactive individuals with interstitial lung disease
Objective: To investigate the relationship between the timed "up and go" (TUG) test and physical activity in daily life (PADL) in patients with interstitial lung disease (ILD) and propose a cutoff point to identify physically inactive individuals. Methods: Participants performed the TUG test at a usual pace (TUGusual) and at a fast pace (TUGfast). Exercise capacity was assessed by the six-minute walk test, lung function was assessed by whole-body plethysmography, quadriceps strength was assessed by maximal voluntary isometric contraction, and PADL was assessed by an activity monitor worn for six consecutive days. PADL variables included number of steps/day, time spent/day in activities of different intensities, and time spent/day in different postures. A ROC curve was plotted to identify physically inactive individuals on the basis of daily steps (5,000 steps/day) and moderate to vigorous physical activity (MVPA; 30 min/day). Results: Fifty-three ILD patients (26 women, with a mean age of 60 ± 11 years) were included in the study. TUGusual and TUGfast correlated moderately with the number of steps/day and time spent/day in light physical activity and MVPA (-0.60 < r < -0.41; p < 0.05 for all). ROC curves for TUGusual showed that the cutoffs of = 9.25 s and = 7.9 s can identify physically inactive individuals on the basis of 5,000 steps/day (AUC: 0.73; sensitivity, 76%; specificity, 70%) and 30 min/day of MVPA (AUC: 0.85; sensitivity, 90%; specificity, 75%). Participants who performed worse on TUGusual (i.e., = 9.25 s) showed lower peripheral muscle strength, exercise capacity, and PADL. Conclusions: Performance on TUGusual and TUGfast correlates moderately with PADL in patients with ILD. A TUGusual performance = 9.25 s appears to be able to identify physically inactive individuals in this population.
- 4 February 2025
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 51 (1) , e20240248
Open AccessTimed “up and go” to identify physically inactive individuals with interstitial lung disease
Objective: To investigate the relationship between the timed "up and go" (TUG) test and physical activity in daily life (PADL) in patients with interstitial lung disease (ILD) and propose a cutoff point to identify physically inactive individuals. Methods: Participants performed the TUG test at a usual pace (TUGusual) and at a fast pace (TUGfast). Exercise capacity was assessed by the six-minute walk test, lung function was assessed by whole-body plethysmography, quadriceps strength was assessed by maximal voluntary isometric contraction, and PADL was assessed by an activity monitor worn for six consecutive days. PADL variables included number of steps/day, time spent/day in activities of different intensities, and time spent/day in different postures. A ROC curve was plotted to identify physically inactive individuals on the basis of daily steps (5,000 steps/day) and moderate to vigorous physical activity (MVPA; 30 min/day). Results: Fifty-three ILD patients (26 women, with a mean age of 60 ± 11 years) were included in the study. TUGusual and TUGfast correlated moderately with the number of steps/day and time spent/day in light physical activity and MVPA (-0.60 < r < -0.41; p < 0.05 for all). ROC curves for TUGusual showed that the cutoffs of = 9.25 s and = 7.9 s can identify physically inactive individuals on the basis of 5,000 steps/day (AUC: 0.73; sensitivity, 76%; specificity, 70%) and 30 min/day of MVPA (AUC: 0.85; sensitivity, 90%; specificity, 75%). Participants who performed worse on TUGusual (i.e., = 9.25 s) showed lower peripheral muscle strength, exercise capacity, and PADL. Conclusions: Performance on TUGusual and TUGfast correlates moderately with PADL in patients with ILD. A TUGusual performance = 9.25 s appears to be able to identify physically inactive individuals in this population.
- Open Access
- 15 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6887
Functional Measures in Non-COPD Chronic Respiratory Diseases: A Systematic Review
Background/Objectives: The extensive range of instruments designed for evaluating functional performance (FP) in chronic respiratory diseases (CRD) other than chronic obstructive pulmonary disease (COPD) presents a challenge in selecting the most appropriate one. Therefore, this systematic review aimed to summarise FP instruments, their measurement properties, their minimum clinically important differences, and their associations with CRD course-related events or prognosis in non-COPD CRD. Methods: Studies employing patient-reported or performance-based instruments to assess FP in non-COPD CRD were systematically identified in the PubMed, PEDro, Embase, and Cochrane Library databases. COPD-exclusive studies or those solely reporting exercise capacity tests were excluded. Examination focused on measurement properties and associations with CRD course-related events or prognosis. The risk of bias was evaluated using the COSMIN, Downs and Black, and PEDro checklists based on the study design. Results: A total of 216 studies across seven CRD categories [asthma, bronchiectasis, cystic fibrosis, interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), pre-/post-lung-transplantation] from various study types were included. Thirty-three instruments were identified, with the SF-36 questionnaire’s physical function domain being the most commonly used patient-reported tool. The 1 min sit-to-stand test was the most extensively studied performance-based measure, with its measurement properties frequently reported in non-COPD CRD studies. Associations with events were infrequently documented, primarily in ILD and PAH studies related to mortality. Conclusions: Despite the prevalent use of FP instruments, limited information exists concerning their measurement properties and clinical implications. This review furnishes a concise summary of available evidence, aiding informed clinical decisions when selecting FP tools for non-COPD CRD.
- 15 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (22) , 6887
Open AccessFunctional Measures in Non-COPD Chronic Respiratory Diseases: A Systematic Review
Background/Objectives: The extensive range of instruments designed for evaluating functional performance (FP) in chronic respiratory diseases (CRD) other than chronic obstructive pulmonary disease (COPD) presents a challenge in selecting the most appropriate one. Therefore, this systematic review aimed to summarise FP instruments, their measurement properties, their minimum clinically important differences, and their associations with CRD course-related events or prognosis in non-COPD CRD. Methods: Studies employing patient-reported or performance-based instruments to assess FP in non-COPD CRD were systematically identified in the PubMed, PEDro, Embase, and Cochrane Library databases. COPD-exclusive studies or those solely reporting exercise capacity tests were excluded. Examination focused on measurement properties and associations with CRD course-related events or prognosis. The risk of bias was evaluated using the COSMIN, Downs and Black, and PEDro checklists based on the study design. Results: A total of 216 studies across seven CRD categories [asthma, bronchiectasis, cystic fibrosis, interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), pre-/post-lung-transplantation] from various study types were included. Thirty-three instruments were identified, with the SF-36 questionnaire’s physical function domain being the most commonly used patient-reported tool. The 1 min sit-to-stand test was the most extensively studied performance-based measure, with its measurement properties frequently reported in non-COPD CRD studies. Associations with events were infrequently documented, primarily in ILD and PAH studies related to mortality. Conclusions: Despite the prevalent use of FP instruments, limited information exists concerning their measurement properties and clinical implications. This review furnishes a concise summary of available evidence, aiding informed clinical decisions when selecting FP tools for non-COPD CRD.
- Open Access
- 1 July 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (7) , e4710
Influência do treinamento proprioceptivo no controle postural de atletas de ginástica rítmica
Introdução: A Ginástica Rítmica (GR) integra treinamento de alta performance, educação e influências culturais. O desempenho depende de coordenação motora e flexibilidade. No Brasil, lesões em tornozelo e joelho são comuns. A propriocepção é crucial na prevenção de lesões. Materiais e Métodos: Estudo de caso com nove atletas femininas de GR (13-16 anos) da UNOPAR. Controle postural avaliado com a plataforma de força BIOMEC400, medindo deslocamento e velocidade de oscilação do COP. Dados coletados antes e após três fases do programa de exercícios sensório-motores, realizados três vezes por semana. Análise estatística com ANOVA de medidas repetidas e correções, significância de 5%. Resultados: Após 90 dias, houve melhora significativa no equilíbrio postural. A área do COP e as velocidades de oscilação diminuíram nas posições bipodal e unipodal. Discussão: O treinamento proprioceptivo melhorou o equilíbrio postural e a estabilidade articular, conforme indicado pela redução na área do COP e velocidades de oscilação. Conclusão: O protocolo proprioceptivo específico melhorou significativamente o equilíbrio e a estabilidade postural em atletas de GR.
- 1 July 2024
- Published by Brazilian Journals in Cuadernos de Educación y Desarrollo
- Vol. 16 (7) , e4710
Open AccessInfluência do treinamento proprioceptivo no controle postural de atletas de ginástica rítmica
Introdução: A Ginástica Rítmica (GR) integra treinamento de alta performance, educação e influências culturais. O desempenho depende de coordenação motora e flexibilidade. No Brasil, lesões em tornozelo e joelho são comuns. A propriocepção é crucial na prevenção de lesões. Materiais e Métodos: Estudo de caso com nove atletas femininas de GR (13-16 anos) da UNOPAR. Controle postural avaliado com a plataforma de força BIOMEC400, medindo deslocamento e velocidade de oscilação do COP. Dados coletados antes e após três fases do programa de exercícios sensório-motores, realizados três vezes por semana. Análise estatística com ANOVA de medidas repetidas e correções, significância de 5%. Resultados: Após 90 dias, houve melhora significativa no equilíbrio postural. A área do COP e as velocidades de oscilação diminuíram nas posições bipodal e unipodal. Discussão: O treinamento proprioceptivo melhorou o equilíbrio postural e a estabilidade articular, conforme indicado pela redução na área do COP e velocidades de oscilação. Conclusão: O protocolo proprioceptivo específico melhorou significativamente o equilíbrio e a estabilidade postural em atletas de GR.
- Open Access
- 25 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (23) , 7314
Clinical Characteristics of Individuals with Interstitial Lung Diseases and Indication of End-of-Life Care
End-of-life care (EOLC) is palliative support provided in the last 6 months to 1 year of a patient’s life. Although there are established criteria for its indication, few studies describe the clinical and functional characteristics of individuals with interstitial lung diseases (ILD) in EOLC. ILD individuals underwent various assessments, including lung function, exercise capacity (6 min walk test), physical activity in daily life (PADL), peripheral muscle strength, maximal respiratory pressures, body composition, quality of life (SGRQ-I), symptoms of anxiety and depression, dyspnea (MRC scale), and sleep quality. Fifty-eight individuals were included and divided into two groups according to the indication for commencing EOLC (ILD with an indication of EOLC (ILD-EOLC) or ILD without an indication of EOLC (ILD-nEOLC). There were differences between the groups, respectively, for steps/day (2328 [1134–3130] vs. 5188 [3863–6514] n/day, p = 0.001), time spent/day carrying out moderate-to-vigorous physical activities (1 [0.4–1] vs. 10 [3–19] min/day, p = 0.0003), time spent/day in standing (3.8 [3.2–4.5] vs. 4.8 [4.1–6.7] h/day, p = 0.005), and lying positions (5.7 [5.3–6.9] vs. 4.2 [3.6–5.1] h/day, p = 0.0004), the sit-to-stand test (20 ± 4 vs. 26 ± 7 reps, p = 0.01), 4 m gait speed (0.92 ± 0.21 vs. 1.05 ± 0.15 m/s, p = 0.02), quadriceps muscle strength (237 [211–303] vs. 319 [261–446] N, p = 0.005), SGRQ-I (71 ± 15 vs. 50 ± 20 pts, p = 0.0009), and MRC (4 [3–5] vs. 2 [2–3] pts, p = 0.001). ILD individuals with criteria for commencing EOLC exhibit reduced PADL, functional performance, peripheral muscle strength, quality of life, and increased dyspnea.
- 25 November 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (23) , 7314
Open AccessClinical Characteristics of Individuals with Interstitial Lung Diseases and Indication of End-of-Life Care
End-of-life care (EOLC) is palliative support provided in the last 6 months to 1 year of a patient’s life. Although there are established criteria for its indication, few studies describe the clinical and functional characteristics of individuals with interstitial lung diseases (ILD) in EOLC. ILD individuals underwent various assessments, including lung function, exercise capacity (6 min walk test), physical activity in daily life (PADL), peripheral muscle strength, maximal respiratory pressures, body composition, quality of life (SGRQ-I), symptoms of anxiety and depression, dyspnea (MRC scale), and sleep quality. Fifty-eight individuals were included and divided into two groups according to the indication for commencing EOLC (ILD with an indication of EOLC (ILD-EOLC) or ILD without an indication of EOLC (ILD-nEOLC). There were differences between the groups, respectively, for steps/day (2328 [1134–3130] vs. 5188 [3863–6514] n/day, p = 0.001), time spent/day carrying out moderate-to-vigorous physical activities (1 [0.4–1] vs. 10 [3–19] min/day, p = 0.0003), time spent/day in standing (3.8 [3.2–4.5] vs. 4.8 [4.1–6.7] h/day, p = 0.005), and lying positions (5.7 [5.3–6.9] vs. 4.2 [3.6–5.1] h/day, p = 0.0004), the sit-to-stand test (20 ± 4 vs. 26 ± 7 reps, p = 0.01), 4 m gait speed (0.92 ± 0.21 vs. 1.05 ± 0.15 m/s, p = 0.02), quadriceps muscle strength (237 [211–303] vs. 319 [261–446] N, p = 0.005), SGRQ-I (71 ± 15 vs. 50 ± 20 pts, p = 0.0009), and MRC (4 [3–5] vs. 2 [2–3] pts, p = 0.001). ILD individuals with criteria for commencing EOLC exhibit reduced PADL, functional performance, peripheral muscle strength, quality of life, and increased dyspnea.
- Open Access
- 1 July 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (9)
Relação entre a carga de trabalho e sintomas no teste ergométrico em pacientes com doenças pulmonares intersticiais e em indivíduos saudáveis
Introdução: As doenças pulmonares intersticiais (DPI) apresentam características clínicas semelhantes caracterizadas por dispneia e intolerância ao exercício. Essas características se acentuam durante o esforço físico, embora isso ainda não tenha sido investigado em profundidade nessa população. Objetivos: Comparar a sensação subjetiva de dispneia e fadiga por carga de trabalho durante o teste ergométrico (TE) entre pacientes com DPI e indivíduos saudáveis. Métodos: Os indivíduos realizaram o TE em cicloergômetro com protocolo incremental. A cada estágio do teste foram coletados a sensação de esforço pela escala de Borg de dispneia (D) e fadiga (F). As inclinações das curvas de D e F por estágio no teste foram comparadas por meio de regressão linear utilizando o método Zar (teste F). Resultados: Foram estudados 37 pacientes com DPI e 29 controles. O grupo DPI apresentou menor carga máxima (60[40-80] vs saudáveis 120[100-160]; (P<.0001) e maiores sintomas ao final do teste para D (P=0,02), mas não para F (P=0,23) quando comparados ao controle. Ainda, o grupo DPI apresentou mais sintomas por watt (i.e. Borg/Wattts) no TE comparado ao grupo controle para D (8x10-2±7x10-2 vs 2x10-2 ± 2x10-2; P=0,0007) e F (1x10-1± 9x10-2 vs 3x10-2 ± 1x10-2; P=0,001). A inclinação das curvas Borg/watts diferiu entre os grupos, com DPI apresentando mais sintomas de D e F por watt (P<0.05 entre as curvas). Conclusão: Pacientes com DPI apresentarem menor capacidade máxima de exercício e parecem apresentar um aumento mais acentuado na sensação de D e F por carga de trabalho durante o TE.
- 1 July 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (9)
Open AccessRelação entre a carga de trabalho e sintomas no teste ergométrico em pacientes com doenças pulmonares intersticiais e em indivíduos saudáveis
Introdução: As doenças pulmonares intersticiais (DPI) apresentam características clínicas semelhantes caracterizadas por dispneia e intolerância ao exercício. Essas características se acentuam durante o esforço físico, embora isso ainda não tenha sido investigado em profundidade nessa população. Objetivos: Comparar a sensação subjetiva de dispneia e fadiga por carga de trabalho durante o teste ergométrico (TE) entre pacientes com DPI e indivíduos saudáveis. Métodos: Os indivíduos realizaram o TE em cicloergômetro com protocolo incremental. A cada estágio do teste foram coletados a sensação de esforço pela escala de Borg de dispneia (D) e fadiga (F). As inclinações das curvas de D e F por estágio no teste foram comparadas por meio de regressão linear utilizando o método Zar (teste F). Resultados: Foram estudados 37 pacientes com DPI e 29 controles. O grupo DPI apresentou menor carga máxima (60[40-80] vs saudáveis 120[100-160]; (P<.0001) e maiores sintomas ao final do teste para D (P=0,02), mas não para F (P=0,23) quando comparados ao controle. Ainda, o grupo DPI apresentou mais sintomas por watt (i.e. Borg/Wattts) no TE comparado ao grupo controle para D (8x10-2±7x10-2 vs 2x10-2 ± 2x10-2; P=0,0007) e F (1x10-1± 9x10-2 vs 3x10-2 ± 1x10-2; P=0,001). A inclinação das curvas Borg/watts diferiu entre os grupos, com DPI apresentando mais sintomas de D e F por watt (P<0.05 entre as curvas). Conclusão: Pacientes com DPI apresentarem menor capacidade máxima de exercício e parecem apresentar um aumento mais acentuado na sensação de D e F por carga de trabalho durante o TE.
- 1 August 2021
- Published by Elsevier in Respiratory Medicine
- Vol. 184, 106413
Functional performance tests in interstitial lung disease: Impairment and measurement properties
- 1 August 2021
- Published by Elsevier in Respiratory Medicine
- Vol. 184, 106413
Functional performance tests in interstitial lung disease: Impairment and measurement properties
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Fisioterapia em Movimento
- Vol. 34
Ultrasonic therapy modulates the expression of genes related to neovascularization and inflammation in fibroblasts
Introduction: In the rehabilitation of musculoskeletal injuries, ultrasound is widely used in clinical practice. Objective: To evaluate the effects of pulsed ultrasonic therapy on the viability and modulation of genes involved in inflammation (IL-6) and neovascularization (VEGF) processes of L929 fibroblast cells. Methods: For irradiation with ultrasound the cells were subdivided into groups: G1 (without irradiation), G2 (0.3 W/cm2-20%) and G3 (0.6 W/cm2-20%), with periods of treatment at 24, 48 and 72 hours. The cell viability assay was analyzed by the MTT method and gene modulation was analyzed by RT-qPCR method. Results: After the comparative analysis between groups, only G2 and G3 (48-hour) presented statistically significant differences in relation to the control. In relation to the gene expression, the selection of the groups analyzed was delimited according to the comparative analysis of the values obtained by the MTT test. After the achievement of RT-qPCR, it could be observed that in G2 the amount of VEGF gene transcripts increased by 1.125-fold compared to endogenous controls, and increased 1.388-fold in G3. The IL-6 gene, on the other hand, had its transcripts reduced in both G2 (5.64x10-9) and G3 (1.91x10-6). Conclusion: Pulsed ultrasound in L929 fibroblasts showed a significant biostimulatory effect in the 48-hour period, with increased cell viability, and the same effect in the modulation of gene expression related the neovascularization and inflammation, mediating the acceleration of the tissue repair cascade.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Fisioterapia em Movimento
- Vol. 34
Open AccessUltrasonic therapy modulates the expression of genes related to neovascularization and inflammation in fibroblasts
Introduction: In the rehabilitation of musculoskeletal injuries, ultrasound is widely used in clinical practice. Objective: To evaluate the effects of pulsed ultrasonic therapy on the viability and modulation of genes involved in inflammation (IL-6) and neovascularization (VEGF) processes of L929 fibroblast cells. Methods: For irradiation with ultrasound the cells were subdivided into groups: G1 (without irradiation), G2 (0.3 W/cm2-20%) and G3 (0.6 W/cm2-20%), with periods of treatment at 24, 48 and 72 hours. The cell viability assay was analyzed by the MTT method and gene modulation was analyzed by RT-qPCR method. Results: After the comparative analysis between groups, only G2 and G3 (48-hour) presented statistically significant differences in relation to the control. In relation to the gene expression, the selection of the groups analyzed was delimited according to the comparative analysis of the values obtained by the MTT test. After the achievement of RT-qPCR, it could be observed that in G2 the amount of VEGF gene transcripts increased by 1.125-fold compared to endogenous controls, and increased 1.388-fold in G3. The IL-6 gene, on the other hand, had its transcripts reduced in both G2 (5.64x10-9) and G3 (1.91x10-6). Conclusion: Pulsed ultrasound in L929 fibroblasts showed a significant biostimulatory effect in the 48-hour period, with increased cell viability, and the same effect in the modulation of gene expression related the neovascularization and inflammation, mediating the acceleration of the tissue repair cascade.
- 1 May 2019
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 98 (5) , 369-372
Analysis of Cell Viability and Gene Expression After Continuous Ultrasound Therapy in L929 Fibroblast Cells
Objective: This study aimed to analyze cell viability and gene expression interleukin 6 and vascular endothelial growth factor after continuous ultrasound therapy of 1 and 3 MHz in L929 fibroblast cells. Design: The L929 cells were cultivated in 12-well plates and divided into the following five groups: Group 1 (G1), nonirradiated; G2, 0.2 W/cm2–1 MHz; G3, 0.5 W/cm2–1 MHz; G4, 0.2 W/cm2–3 MHz; and G5, 0.5 W/cm2–3 MHz. The cells were irradiated at 24 and 48 hrs. Cell viability was evaluated using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method. The gene expression analysis was assessed using real-time polymerase chain reaction. Results: The G2 and G3 showed a decrease in cell viability when compared with the G1 at 48 hrs (P < 0.01). The G4 and G5 presented an increase in viability (P = 0.01 and P = 0.03, respectively) in 24 to 48 hrs. The cells irradiated at an intensity of 0.5 W/cm2–3 MHz at 48 hrs showed a 0.21-fold decrease in interleukin-6 gene transcripts and a 1.67-fold increase in vascular endothelial growth factor gene transcripts. Conclusions: Continuous ultrasound therapy with a frequency of 3 MHz at an intensity of 0.5 W/cm2 stimulates cell proliferation, decreases interleukin-6 gene expression, and increases vascular endothelial growth factor gene expression in L929 fibroblast cells.
- 1 May 2019
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
- Vol. 98 (5) , 369-372
Analysis of Cell Viability and Gene Expression After Continuous Ultrasound Therapy in L929 Fibroblast Cells
Objective: This study aimed to analyze cell viability and gene expression interleukin 6 and vascular endothelial growth factor after continuous ultrasound therapy of 1 and 3 MHz in L929 fibroblast cells. Design: The L929 cells were cultivated in 12-well plates and divided into the following five groups: Group 1 (G1), nonirradiated; G2, 0.2 W/cm2–1 MHz; G3, 0.5 W/cm2–1 MHz; G4, 0.2 W/cm2–3 MHz; and G5, 0.5 W/cm2–3 MHz. The cells were irradiated at 24 and 48 hrs. Cell viability was evaluated using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method. The gene expression analysis was assessed using real-time polymerase chain reaction. Results: The G2 and G3 showed a decrease in cell viability when compared with the G1 at 48 hrs (P < 0.01). The G4 and G5 presented an increase in viability (P = 0.01 and P = 0.03, respectively) in 24 to 48 hrs. The cells irradiated at an intensity of 0.5 W/cm2–3 MHz at 48 hrs showed a 0.21-fold decrease in interleukin-6 gene transcripts and a 1.67-fold increase in vascular endothelial growth factor gene transcripts. Conclusions: Continuous ultrasound therapy with a frequency of 3 MHz at an intensity of 0.5 W/cm2 stimulates cell proliferation, decreases interleukin-6 gene expression, and increases vascular endothelial growth factor gene expression in L929 fibroblast cells.